CLINICAL ENDOCRINOLOGY, vol.65, no.1, pp.75-80, 2006 (Peer-Reviewed Journal)
Background Women with polycystic ovary syndrome (PCOS) are thought to have increased cardiovascular risk. Metformin therapy reduces whole-body insulin resistance (IR) in patients with type-2 diabetes mellitus (DM).